Research Activities

Research Activities

Home › Research Activities › Principal Investigators › Misao Fujita (Professor)

Principal Investigators

Uehiro Research Div. for iPS Cell Ethics  
Misao Fujita (Professor)


Sawai T, Sakaguchi H, Thomas E, Takahashi J, Fujita M.

The Ethics of Cerebral Organoid Research: Being Conscious of Consciousness Stem Cell Reports. 2019; 13(1):470-477

Ozeki-Hayashi R, Fujita M, Tsuchiya A, Hatta T, Nakazawa E, Takimoto Y, Akabayashi A.

Beliefs held by breast surgeons that impact the treatment decision process for advanced breast cancer patients: a qualitative study. Breast Cancer: Targets and Therapy.2019; 11: 221-229.

Sawai T, Hatta T, Fujita M.

Japan significantly relaxes its human-animal chimeric embryo research regulations. Cell Stem Cell. 2019; 24 (4): 513-51.

Fujita M, Tabuchi K.

A rebuttal to Akabayashi and colleagues' criticisms of the iPSC stock project. Journal of Medical Ethics. 2019; 45(7):476-477.

Sawai T, Hatta T, Fujita M.

The Japanese generally accept human-animal chimeric embryo research but are concerned about human cells contributing to brain and gametes. Stem Cells Translational Medicine. 2017; 6(8): 1749-1750.

Sawai T, Hatta T, Fujita M.

Public attitudes in Japan towards human-animal chimeric embryo research using human induced pluripotent stem cells. Regenerative Medicine. 2017;12(3):233-248.

Takashima K, Takimoto Y, Nakazawa E, Hayashi Y, Tsuchiya A, Fujita M, Akabayashi A.

Discovery and informing study participants of incidental findings detected in brain magnetic resonance imaging studies: review and multi-institutional study. Brain and Behavior. 2017;7(5):e00676.

Sawai T, Fujita M.

The problem of dual use in relation to decoded neurofeedback. AJOB Neuroscience. 2016; 7(4): 253-254.

Fujita M, Hatta T, Reina O, Akabayashi A.

The current status of clinics providing private practice cell therapy in Japan. Regenerative Medicine 2016;11(1):23-32.

Takahashi S, Fujita M, Akabayashi A.

"Mottainai" embryos and the earthquake. J Clin Res Bioeth. 2015;7:258

Ikka T, Fujita M, Yashiro Y, Ikegaya H.

Recent Court Ruling in Japan Exemplifies Another Layer of Regulation for Regenerative Therapy. Cell Stem Cell 2015; 17(5): 507-508.

Fujita M, Hatta T, Sawai T, Takahashi J.

Risk of Tumorigenesis and Patient Hope. AJOB Neuroscience 2015; 6: 69-70.

Fujita M, Hayashi Y, Tashiro S, Takashima K, Nakazawa E, Akabayashi A.

Handling incidental findings in neuroimaging research in Japan: current state of research facilities and attitudes of investigators and the general population. Health Research Policy and Systems 2014; 12: 58.

Fujita M, Yashiro Y, Suzuki M.

Throwing the baby out with the bathwater: a critique of Sparrow's inclusive definition of the term 'in vitro eugenics.' J Med Ethics. 2013 Aug 28.

Takahashi S, Fujita M, Fujimoto A, Fujiwara T, Yano T, Tsutsumi O, Taketani Y, Akabayashi A.

The decision-making process for the fate of frozen embryos by Japanese infertile women: a qualitative study. BMC Medical Ethics 2012; 13: 9.

Fujita M, Matsui K, Monden M, Akabayashi A.

Attitudes of medical professionals and transplant facilities toward living donor liver transplantation in Japan. Transplantation Proceedings 2010; 42: 1453-9.

Fujita M, Slingsby BT, Akabayashi A.

Transplant tourism from Japan. American Journal of Bioethics 2010; 10(2): 24-6.

Akabayashi A, Fujita M.

The present and future of stem cell therapy in Japan. In: Uehiro T (ed). Ethics for the Future of Life, 9-19. Oxford Uehiro Center for Practical Ethics; 2013.
go top